Clover Health Investments, Corp.
CLOV- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001801170
In the last 90 days, Clover Health Investments, Corp. insiders filed 0 open-market purchases and 17 sales; 228 institutions reported holding it in 13F filings for Q3 2026, worth $676.4M in total; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $3.80M in total
- 17
- 13F holdersQ3 2026, +8 vs. previous quarter
- 228
- 13F valueReported value at the end of Q3 2026
- $676.4M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.92B
- +40.3% year over year
- Net income, FY2025
- -$85.5M
- No comparable prior period
- Free cash flow, FY2025
- -$69.0M
- −307.2% year over year
- Revenue, Q3 FY2026
- $759.3M
- +52.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $85.5M (4.4% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 23.0M
- Shares sold short
- Change
- −2.92M
- −11.3% vs. previous
- Days to cover
- 6.73
- At average daily volume
Superinvestors holding CLOV, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding CLOV at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Clover Health Investments, Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)5:03 PM ET | Nov 16 | 1 day | Thornton Joseph ClayChief Financial Officer | SSaleClass A Common Stock | −22.1K | $4.97 | −$109.8K | −1.4%1.55M after | |
| Oct 20, 2026 (view filing)5:56 PM ET | Oct 20 | Same day | Soares KarenChief Legal Officer | SSaleClass A Common Stock | −19.3K | $4.66 | −$89.8K | −1.2%1.57M after | 10b5-1 |
| Oct 20, 2026 (view filing)4:43 PM ET | Oct 19 | 1 day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −4.07K | $4.41 | −$17.9K | −0.1%2.77M after | 10b5-1 |
| Oct 19, 2026 (view filing)4:31 PM ET | Oct 15 | 4 days | Toy AndrewChief Executive Officer | SSaleClass A Common Stock | −62.2K | $4.68 | −$291.0K | −0.7%9.08M after | 10b5-1 |
| Oct 19, 2026 (view filing)4:26 PM ET | Oct 15 | 4 days | Soares KarenChief Legal Officer | SSaleClass A Common Stock | −14.7K | $4.68 | −$68.7K | −0.9%1.59M after | 10b5-1 |
| Oct 19, 2026 (view filing)4:23 PM ET | Oct 15 | 4 days | Thornton Joseph ClayInterim CFO | SSaleClass A Common Stock | −4.59K | $4.68 | −$21.5K | −0.4%1.24M after | 10b5-1 |
| Oct 19, 2026 (view filing)4:22 PM ET | Oct 15 | 4 days | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −23.6K | $4.68 | −$110.6K | −2.2%1.04M after | 10b5-1 |
| Oct 19, 2026 (view filing)4:19 PM ET | Oct 15 | 4 days | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −18.3K | $4.68 | −$85.5K | −0.7%2.77M after | 10b5-1 |
| Oct 7, 2026 (view filing)6:20 PM ET | Oct 7 | Same day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −2.01K | $4.63 | −$9.29K | −0.1%2.79M after | 10b5-1 |
| Oct 5, 2026 (view filing)7:00 PM ET | Oct 5 | Same day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −8.75K | $4.42 | −$38.7K | −0.3%2.79M after | 10b5-1 |
Top 10 13F holders, Q3 2026
See all 228 holdersThe largest institutional positions in Clover Health Investments, Corp. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 36,508,668 | $157.4M | 0.00% | +1,401,703+4.0% | Added |
| Vanguard Capital Management LLC | 18,381,770 | $79.2M | 0.00% | +344,109+1.9% | Added |
| Geode Capital Management, LLC | 11,115,990 | $47.9M | 0.00% | +269,924+2.5% | Added |
| State Street Corp | 10,693,705 | $46.1M | 0.00% | +513,368+5.0% | Added |
| Nuveen, LLC | 7,818,023 | $33.7M | 0.01% | +1,526,324+24.3% | Added |
| Vanguard Portfolio Management LLC | 7,590,927 | $32.7M | 0.00% | +3,120,475+69.8% | Added |
| Charles Schwab Investment Management Inc | 5,859,804 | $25.3M | 0.00% | +338,616+6.1% | Added |
| Renaissance Technologies LLC | 4,554,241 | $19.6M | 0.03% | +1,746,800+62.2% | Added |
| D. E. Shaw & Co., Inc. | 4,382,346 | $18.9M | 0.01% | +2,416,853+123.0% | Added |
| Northern Trust Corp | 3,779,279 | $16.3M | 0.00% | +6,679+0.2% | Added |
Holders of 5% or more of CLOV
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Clover Health Investments, Corp..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G | 7.20%29.8M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |